Area riservata



Chirurgia del tunnel carpale

Commenti agli articoli

Specialistica
A shot of common sense: Canada needs national vaccination strategy
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaCanada needs to harmonize vaccination schedules across the country and establish a national vaccination registry to help address outbreaks of infectious diseases like measles, argues an editorial... ... ...
 
Bacterial adaptation contributes to pneumococcal threat in sickle cell disease patients
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaResearchers have identified differences in the genetic code of pneumococcal bacteria that may explain why it poses such a risk to children with sickle cell disease and why current vaccines don't... ... ...
 
'Encouraging' period of stable disease suggested in direct injection vaccine treatment of pancreatic cancer
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaResearch from Rutgers Cancer Institute of New Jersey shows that the 'first in man' series of vaccine injections given directly into a pancreatic cancer tumor is not only well tolerated, but also... ... ...
 
How streptococcal bacteria can be used to fight colon cancer
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaResearchers at Western University (London, Canada) have shown how the bacteria primarily responsible for causing strep throat can be used to fight colon cancer. ... ...
 
"Battle of the bulge" may be linked to body clock in immune cells
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaIt's all in the timing, according to Texas A&M researchers who have confirmed disruption of the internal biological clock plays a key role in the development of metabolic diseases, including... ... ...
 
How antibodies cluster in solution revealed by neutron beams
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaResults from neutron spin-echo analysis at the Institut Laue-Langevin (ILL) and the National Center of Neutron Research (NCNR) in the United States are an important advance towards enabling... ... ...
 
Favorable phase II data announced for investigational C. difficile vaccine
Scritto da Immune System/Vaccines News From Medical News Today   
AllergologiaSanofi Pasteur, the vaccines division of Sanofi, presented Phase II (H-030-012) trial results for an investigational vaccine for the prevention of Clostridium difficile (C. ... ...
 
<< Inizio < Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>

Pag 2 di 5848